It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Toxoplasma gondii is a cyst-forming apicomplexan parasite of virtually all warm-blooded species, with all true cats (Felidae) as definitive hosts. It is the etiologic agent of toxoplasmosis, a disease causing substantial public health burden worldwide. Few intercontinental clonal lineages represent the large majority of isolates worldwide. Little is known about the evolutionary forces driving the success of these lineages, the timing and the mechanisms of their global dispersal. In this study, we analyse a set of 156 genomes and we provide estimates of T. gondii mutation rate and generation time. We elucidate how the evolution of T. gondii populations is intimately linked to the major events that have punctuated the recent history of cats. We show that a unique haplotype, whose length represents only 0.16% of the whole T. gondii genome, is common to all intercontinental lineages and hybrid populations derived from these lineages. This haplotype has accompanied wildcats (Felis silvestris) during their emergence from the wild to domestic settlements, their dispersal in the Old World, and their expansion in the last five centuries to the Americas. The selection of this haplotype is most parsimoniously explained by its role in sexual reproduction of T. gondii in domestic cats.
Toxoplasma gondii can infect all warm-blooded animals, with felidae being the definitive hosts. Despite this broad host range, most clinical and animal isolates belong to few clonal lineages. Here, Galal et al. perform whole-genome sequencing of isolates from distinct geographical regions and estimate T. gondii mutation rate and generation time. They find that recent waves of migration disseminated the parasite from Old to New World and identify a unique haplotype that likely accompanied the global expansion of cats and is today common to all intercontinental lineages and hybrid populations.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT—Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France
2 Université de Paris, Institut Cochin, Inserm U1016, Service de Parasitologie Hôpital Cochin, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602)
3 DYNAMICURE U1311 INSERM, Université de Caen Normandie, UNICAEN, UNIROUEN, Caen, France (GRID:grid.412043.0) (ISNI:0000 0001 2186 4076); Laboratoire de Virologie, Centre Hospitalo-Universitaire, Avenue Georges Clémenceau, Caen, France (GRID:grid.412043.0); Institut de Recherche pour le Développement (IRD), Maladies Infectieuses et vecteurs: Ecologie, Génétique, Evolution et Contrôle (MIVEGEC) (Université de Montpellier—IRD 224—CNRS 5290), Montpellier, France (GRID:grid.4399.7) (ISNI:0000000122879528)
4 Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT—Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France (GRID:grid.4399.7); Centre National de Référence (CNR) Toxoplasmose/Toxoplasma Biological Center (BRC), Centre Hospitalier-Universitaire Dupuytren, Limoges, France (GRID:grid.412212.6) (ISNI:0000 0001 1481 5225)
5 Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT—Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France (GRID:grid.412212.6)
6 Plate-Forme Séquençage et Génomique, Institut Cochin, Inserm U1016, Université de Paris, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602)
7 IRL REHABS, International Research Laboratory REHABS, CNRS-NMU-UCBL, Nelson Mandela University George Campus, George, South Africa (GRID:grid.412139.c) (ISNI:0000 0001 2191 3608)
8 Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT—Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France (GRID:grid.412139.c); Centre National de Référence (CNR) Toxoplasmose/Toxoplasma Biological Center (BRC), Centre Hospitalier-Universitaire Dupuytren, Limoges, France (GRID:grid.412212.6) (ISNI:0000 0001 1481 5225)